Browse the evidence

Genetic deficiency of leptin causes severe obesity in mice, which is completely reversed by leptin replacement therapy, demonstrating that leptin is essential for maintaining body weight homeostasis.

This finding explains why leptin injections are not a viable treatment for the vast majority of people with obesity. In common obesity, the body already produces high levels of leptin, but the brain fails to respond to it (leptin resistance). Therefore, treatments must address the resistance mechanism or target downstream pathways rather than simply replacing the hormone.

Intensive glycemic control (targeting HbA1c <6.0-6.5%) slows the progression of microvascular complications (retinopathy, nephropathy, neuropathy) in type 2 diabetes, but does not significantly reduce macrovascular events within the first 3-5 years of treatment.

For Type 2 Diabetes, keeping blood sugar very low (HbA1c <6.5%) protects your eyes, kidneys, and nerves, but this protection takes years to show up in heart health. Be aware that aggressive sugar lowering can increase the risk of dangerous low blood sugar episodes, so the target must be balanced carefully with your doctor.

Sleep is an actively generated state by the central nervous system, regulated by homeostatic and circadian processes, rather than a passive loss of wakefulness.

Understand that sleep is an active biological process. Disrupting this active process (e.g., through poor sleep hygiene or disorders) has significant consequences because the brain is actively working to regulate states.

Adopting a low glycemic index (GI) diet does not improve cardiovascular risk factors or insulin sensitivity compared to a high GI diet when total carbohydrate intake is high and other nutrients are controlled.

If you eat a high-carbohydrate diet, switching to 'low glycemic index' foods (like swapping white bread for whole wheat or pasta for lentils) will not necessarily improve your insulin sensitivity or heart health markers. In fact, this study suggests it might slightly worsen insulin sensitivity and raise LDL cholesterol compared to high GI carbs, provided your total calories, fiber, and saturated fat remain constant. Focus on reducing total carbohydrate quantity if you want to improve triglycerides and insulin sensitivity, rather than just swapping carb types.

Specific cytokines (IL-1, TNF, IFN) produced during the immune response act on the brain to increase non-REM sleep duration, demonstrating a bidirectional communication between the immune system and sleep regulation.

Your immune system uses chemical signals (cytokines) to tell your brain to sleep more when you are sick. This is a biological command to prioritize healing over other activities.

Chronic inhibition of mTORC2 by rapamycin causes metabolic dysfunction (glucose intolerance, insulin resistance) and immunosuppression, acting as the primary barrier to its use as an anti-aging therapy.

Chronic daily use of rapamycin is likely unsafe for long-term anti-aging due to the risk of diabetes and immune suppression caused by mTORC2 inhibition. This mechanism explains why 'more is not better' with this drug.

Genetic predisposition to obesity, particularly variants in FTO and MC4R, increases the risk of type 2 diabetes, cardiovascular disease, and certain cancers primarily through its effect on BMI, establishing a causal link between obesity and these comorbidities.

If you have a family history of obesity, recognize that your genetic risk may make you more susceptible to weight gain and related metabolic issues. This doesn't mean you are doomed, but it does mean you should prioritize preventive lifestyle measures (diet, activity) earlier and more consistently than those without such risk factors.

Insulin resistance drives NAFLD pathogenesis through two main mechanisms: increased adipose tissue lipolysis (free fatty acid overflow) and increased hepatic de novo lipogenesis (fatty acid synthesis), leading to triglyceride accumulation.

Addressing insulin resistance is the most critical step in managing fatty liver. This involves caloric restriction, weight loss, and dietary changes that reduce insulin spikes, thereby reducing both the release of fatty acids from fat tissue and the liver's production of new fat.

Ectopic lipid accumulation in non-adipose tissues (liver, muscle) causes insulin resistance primarily through diacylglycerol and ceramide signaling, not triglyceride storage itself.

Insulin resistance in obesity is driven by specific fat molecules (DAG and ceramide) that interfere with insulin signaling, not just the total amount of fat stored in organs.

Ghrelin is an orexigenic hormone that stimulates food intake and reduces energy expenditure by activating NPY/AgRP neurons in the hypothalamus, acting in opposition to leptin.

Ghrelin is your body's natural 'hunger hormone' that rises before meals and falls after eating. It works by stimulating specific brain neurons (NPY/AgRP) to increase food intake and reduce fat burning. To manage energy balance, recognize that ghrelin levels naturally fluctuate with fasting and feeding; strategies that stabilize blood sugar and maintain muscle mass can help modulate these natural hormonal swings.

Manipulating dietary Glycemic Index (GI) or Glycemic Load (GL) does not provide a significant benefit for weight loss, satiety, or cardiometabolic risk factors compared to isocaloric high-GI diets when fiber and energy intake are controlled.

Stop obsessing over the Glycemic Index for weight loss or health. The science shows that swapping high-GI foods for low-GI ones does not help you lose more weight or feel fuller, provided you eat the same amount of calories and fiber. Focus on eating whole foods, vegetables, and fiber-rich carbohydrates instead of calculating GI numbers. If you enjoy high-GI foods like white rice or potatoes, include them as part of a balanced meal with fiber and protein; they will not sabotage your health goals.

Women with diabetes have a 30% greater excess risk of cardiovascular disease (CVD) mortality compared to men with diabetes, driven largely by a higher risk of coronary heart disease (CHD) mortality.

Women with diabetes face a 30% higher relative risk of dying from heart disease than men with diabetes. This underscores the importance of rigorous cardiovascular monitoring and prevention for women, potentially requiring more aggressive management than standard protocols might imply.

M2 macrophages sustain insulin sensitivity by secreting IL-4 and IL-10, whereas M1 macrophages induce insulin resistance through proinflammatory cytokines like TNFα.

The type of immune cells in fat tissue matters. M2 macrophages help insulin work, while M1 macrophages hinder it. Maintaining a balance favoring M2 activity may support metabolic health.

Successful long-term weight loss maintenance likely requires targeting multiple redundant hormonal systems simultaneously rather than a single molecule.

Treating obesity is complex because your body has multiple redundant systems that fight weight loss. Relying on a single drug or diet strategy is unlikely to work long-term. Effective management likely involves addressing multiple aspects of your biology and lifestyle simultaneously.

DPP-4 inhibitors lower hyperglycemia in type 2 diabetes by preventing the degradation of incretin hormones (GLP-1 and GIP), thereby potentiating glucose-dependent insulin secretion.

DPP-4 inhibitors are a common diabetes medication that works by protecting your body's natural hormones (GLP-1 and GIP) from being broken down. This helps your pancreas release more insulin when you eat, lowering blood sugar without causing hypoglycemia in most cases.

Metformin blunts increases in thigh muscle area and density resulting from progressive resistance training in older adults.

Metformin reduces the structural improvements (area and density) you get from weight training. This might be due to increased fat inside muscle cells. Talk to your doctor about your medication if muscle growth is a priority.

Metformin does not affect muscle fiber hypertrophy (cross-sectional area) or satellite cell abundance in response to progressive resistance training in older adults.

While metformin reduces overall muscle size, it doesn't seem to stop individual muscle fibers from growing. The issue may be related to fat content or other factors, not the fiber size itself.

Insulin resistance is a key pathophysiological factor in NAFLD, creating a bidirectional relationship where insulin resistance leads to liver fat accumulation and liver fat accumulation worsens insulin sensitivity.

Focus on improving insulin sensitivity. This involves managing weight, reducing refined carbs, and regular exercise. It helps both the liver and metabolic health.

Genetic variants can confound the association between DNA methylation and metabolic traits, creating apparent epigenetic links that are actually driven by genetics.

When looking at epigenetic studies, it's crucial to distinguish between true epigenetic changes and those driven by genetics. This study shows that some apparent epigenetic links to metabolism are actually just reflections of your DNA sequence. Always check if genetic confounders have been accounted for.

Functional S6K1 is required for the anorectic effects of both leptin and CNTFAx15.

This finding highlights that the brain's ability to process appetite-suppressing signals depends on a specific protein (S6K1). If this protein is not functioning, common appetite-regulating hormones like leptin cannot work effectively.

Weightlessness and reduced mechanical loading (e.g., spaceflight, bed rest) cause rapid, site-specific bone loss, particularly in weight-bearing bones, with recovery being significantly slower than the rate of loss.

Prolonged periods of reduced weight-bearing activity, such as bed rest or sedentary living, lead to rapid bone loss, especially in the hips and spine. Recovery of bone density is slow and incomplete. Regular weight-bearing exercise is essential to counteract these effects.

Obesity and Type 2 Diabetes impair the insulin-induced suppression of hepatic glycogenolysis and gluconeogenesis, leading to excessive endogenous glucose production.

In obesity and Type 2 Diabetes, the liver fails to stop producing glucose even when insulin signals it to. This is not just about high glucagon; the insulin signal itself is ignored. Managing this requires addressing the underlying insulin resistance and free fatty acid levels, rather than just targeting glucagon.

Anti-TNF-alpha therapies (e.g., infliximab) fail to improve insulin sensitivity in type 2 diabetes patients, whereas they successfully reduce insulin resistance in patients with high-grade inflammatory diseases like rheumatoid arthritis.

Taking anti-inflammatory drugs like TNF inhibitors will not fix insulin resistance if your primary issue is obesity or metabolic syndrome. These drugs work for autoimmune conditions, but for metabolic health, focusing on reducing saturated fats and weight is the effective path.

Thyroid hormone T3 stimulates metabolic rate and thermogenesis primarily through nuclear mechanisms that alter gene transcription, rather than through direct non-nuclear uncoupling of oxidative phosphorylation.

Your metabolic rate is heavily influenced by thyroid hormone levels, specifically T3, which acts by changing gene expression in your cells. While extreme thyroid dysfunction (hypo- or hyperthyroidism) drastically alters BMR, normal physiological variations are tightly regulated. There is no evidence that 'boosting' thyroid hormones beyond normal ranges is a safe or effective strategy for weight loss, as it disrupts homeostasis and can be harmful. Focus on maintaining overall health rather than targeting thyroid-specific metabolic hacks.